EUVIMEDScopri EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series

Peter Kramer iD, Bernd Opgen-Rhein, Felix Berger, Johannes Nordmeyer

Catheterization and Cardiovascular Interventions · 2023

DOI: 10.1002/ccd.30747 ↗

At a glance

Fallbericht in Catheterization and Cardiovascular Interventions, 2023. Written by Peter Kramer and 3 co-authors. Institution: Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany. Major MEDLINE topics: Septal Occluder Device, Atrial Fibrillation, Heart Septal Defects, Atrial, Foramen Ovale, Patent. Cited 2 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Device thromboses after patent foramen ovale (PFO) and atrial septal defect (ASD) closure are rare but serious complications. They have been reported in different devices of virtually all manufacturers. Here, we report three cases of left atrial device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder (GSO) in our recent institutional experience. All patients were symptomatic with new‐onset neurological impairments and evidence of cerebral thromboembolism. Device thromboses have occurred despite antiplatelet therapy in two patients and moreover were observed late, at approximately 2 years after implantation, in two patients. One device was surgically explanted while in two cases, thrombi completely resolved with initiated anticoagulation. All patients had a favorable neurological recovery. Our observations suggest that regular follow‐up echocardiography beyond 6 months after device implantation might be advisable in patients with GSO devices to rule out late device thromboses. More long‐term follow‐up data considering safety and late complications of contemporary PFO and ASD devices is required to establish confident evidence‐based recommendations on long‐term follow‐up management and antithrombotic therapy regimen after PFO and ASD closure.

Subjects

MeSH terms (MEDLINE)

Septal Occluder DeviceAtrial FibrillationHeart Septal Defects, AtrialForamen Ovale, PatentThrombosisHumansTreatment OutcomeCardiac CatheterizationProsthesis Design

Author keywords

Gore® Cardioform septal occluderdevice thrombosispatent foramen ovale closuresecundum type atrial septal defect closure

Authors and institutions

  • Department of Congenital Heart Disease - Pediatric Cardiology, Deutsches Herzzentrum der Charité, Berlin, Germany.
  • Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.

ORCID profiles: Peter Kramer

Cite

APA

Kramer, P., Opgen-Rhein, B., Berger, F., & Nordmeyer, J. (2023). Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30747

Vancouver

Kramer P, Opgen-Rhein B, Berger F, Nordmeyer J. Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30747

BibTeX
@article{Kramer2023,
  author = {Kramer, Peter and Opgen-Rhein, Bernd and Berger, Felix and Nordmeyer, Johannes},
  title = {Left atrial disc device thrombosis after atrial defect closure with the Gore® Cardioform septal occluder: A case series},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2023},
  doi = {10.1002/ccd.30747}
}
Start for free →